Realization of the Stereotaxic Surgery

  • Barbara Ferry
  • Damien Gervasoni
  • Catherine Vogt
Chapter

Abstract

For addressing the specific objectives of a proposed study, stereotaxic surgery is often used in combination with other techniques. These techniques can include in vivo experimental procedures for activating or inactivating brain structures or transmitter systems, permanent selective lesioning, functional neuroanatomy using tracers and activity markers, and acute or chronic measurements or recordings. Through three examples, this chapter covers the practical realization of a stereotaxic surgery in combination with several techniques: the insertion of a guide cannula for pharmacological microinjections or optogenetic manipulations in rats, the insertion of glass microelectrode in a model of head-restrained rat for semi-chronic electrophysiological recordings and a procedure of microdialysis in the anesthetized mouse. To ensure a proper conduct of such complex stereotaxic surgeries, these procedures are thoroughly described with the preparation of the surgical tools, the adequate protocols for anesthesia and analgesia, and the method to verify the correct placement of the cannula or probe on the stereotaxic holder. The main surgical gestures and procedures including drilling, mounting of anchor screws and fixing cannula and screws with cement are detailed. Through these examples, this chapter is aimed to help users to adequately prepare and perform their own surgeries, in order to obtain an optimal precision and reproducibility in their procedures, with a constant care of the animal’s welfare.

Keywords

Dura Mater Microdialysis Probe Guide Cannula Dental Cement Stereotaxic Apparatus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Berridge KC, Whishaw IQ (1992) Cortex, striatum and cerebellum: control of serial order in a grooming sequence. Exp Brain Res 90(2):275–290CrossRefPubMedGoogle Scholar
  2. Blasiak T, Czubak W, Ignaciak A, Lewandowski MH (2010) A new approach to detection of the bregma point on the rat skull. J Neurosci Methods 185(2):199–203Google Scholar
  3. Blum D, Torch S, Lambeng N et al (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson’s disease. Prog Neurobiol 65(2):135–172CrossRefPubMedGoogle Scholar
  4. Buchen L (2010) Illuminating the brain. Nature 465:26–28CrossRefPubMedGoogle Scholar
  5. Centonze D, Calabresi P, Giacomini P, Bernardi G (1999) Neurophysiology of Parkinson’s disease: from basic research to clinical correlates. Clin Neurophysiol 110(12):2006–2013CrossRefPubMedGoogle Scholar
  6. Chen Z, Ong BH, Kambouris NG, Marban E, Tomaselli GF, Balser JR (2000) Lidocaine induces a slow inactivated state in rat skeletal muscle sodium channels. J Physiol 524:37–49CrossRefPubMedCentralPubMedGoogle Scholar
  7. Dudley MW, Howard BD, Cho AK (1990) The interaction of the beta-haloethyl benzylamines, xylamine, and DSP-4 with catecholaminergic neurons. Annu Rev Pharmacol Toxicol 30:387–403CrossRefPubMedGoogle Scholar
  8. Duncan RJS, Sourkes TL, Dubrovsky BO, Quik M (1975) Activity of aldehyde dehydrogenase, aldehyde reductase and acetylcholine esterase in striatum of rats bearing electrolytic lesions of the medial forebrain bundle. J Neurochem 24(1):143–147CrossRefPubMedGoogle Scholar
  9. Ferry B, McGaugh JL (2008) Involvement of the basolateral amygdala α2-adrenoceptors in memory modulation of inhibitory avoidance in the rat. Learn Mem 15(4):238–243CrossRefPubMedCentralPubMedGoogle Scholar
  10. Ferry B, Sandner G, Di Scala G (1995) Neuroanatomical and functional specificity of basolateral amygdaloid nucleus in taste potentiated odor aversion. Neurobiol Learn Mem 64:169–180CrossRefPubMedGoogle Scholar
  11. Ferry B, Wirth S, Di Scala G (1999) Functional interaction between entorhinal cortex and basolateral amygdala during trace conditioning of odor aversion in the rat. Behav Neurosci 113(1):118–125CrossRefPubMedGoogle Scholar
  12. Fritschy JM, Grzanna R (1991) Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system? Prog Brain Res 88:257–268CrossRefPubMedGoogle Scholar
  13. Gervasoni D, Darracq L, Fort P, Souliere S, Chouvet G, Luppi PH (1998) Electrophysiological evidence that noradrenergic neurons of the locus coeruleus are tonically inhibited by GABA during sleep. Eur J Neurosci 10:964–970CrossRefPubMedGoogle Scholar
  14. Gervasoni D, Peyron C, Rampon C et al (2000) Role and origin of the GABAergic innervations of dorsal raphe serotonergic neurones. J Neurosci 20:4217–4225PubMedGoogle Scholar
  15. Glinka Y, Gassen M, Youdim MB (1997) Mechanism of 6-hydroxydopamine neurotoxicity. J Neural Transm 50:55–66CrossRefGoogle Scholar
  16. Goldstein LB (1993) Beam-walking in rats: the measurement of motor recovery after injury to the cerebral cortex. Neurosci Protoc 10(3):1–13Google Scholar
  17. Jarrard LE (2002) Use of excitotoxins to lesion the hippocampus: update. Hippocampus 12(3):405–414CrossRefPubMedGoogle Scholar
  18. Jonsson G (1980) Chemical neurotoxins as denervation tools in neurobiology. Annu Rev Neurosci 3:169–187CrossRefPubMedGoogle Scholar
  19. King BM (1991) Comparison of electrolytic and radio-frequency and lesion methods. Methods Neurosci 7:90–97CrossRefGoogle Scholar
  20. Kostrzewa RM (1995) Dopamine receptor supersensitivity. Neurosci Biobehav Rev 19(1):1–17CrossRefPubMedGoogle Scholar
  21. Kostrzewa RM (2009) Evolution of neurotoxins: from research modalities to clinical realities. Curr Protoc Neurosci 1: Unit 1.18Google Scholar
  22. Kostrzewa RM, Brus R (1998) Destruction of catecholamine-containing neurons by 6-hydroxydopa, an endogenous amine oxidase cofactor. Amino Acids 14(1–3):175–179CrossRefPubMedGoogle Scholar
  23. Li Y, Peris J, Zhong L, Derendorf H (2006) Microdialysis as a tool in local pharmacodynamics. AAPS J 8(2):222–235CrossRefGoogle Scholar
  24. Livingston-Thomas JM, Hume AW, Doucette TA, Tasker RA (2013) A novel approach to induction and rehabilitation of deficits in forelimb function in a rat model of ischemic stroke. Acta Pharmacol Sin 34(1):104–112CrossRefPubMedCentralPubMedGoogle Scholar
  25. McGaughy J, Everitt BJ, Robbins TW, Sarter M (2000) The role of cortical cholinergic afferent projections in cognition: impact of new selective immunotoxins. Behav Brain Res 115(2):251–263CrossRefPubMedGoogle Scholar
  26. Messier C, Emond S, Ethier K (1998) New techniques in stereotaxic surgery and anesthesia in the mouse. Pharmacol Biochem Behav 63(2):313–318CrossRefGoogle Scholar
  27. Milner TA, Amaral DG (1984) Evidence for a ventral septal projection to the hippocampal formation of the rat. Exp Brain Res 55(3):579–585CrossRefPubMedGoogle Scholar
  28. Rotman A, Creveling CR (1976) A rationale for the design of cell-specific toxic agents: the mechanism of action of 6-hydroxydopamine. FEBS Lett 72(2):227–230CrossRefPubMedGoogle Scholar
  29. Schliebs R, Rossner S, Bigl V (1996) Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: a useful tool to produce cortical cholinergic dysfunction. Prog Brain Res 109:253–264CrossRefPubMedGoogle Scholar
  30. Schwarting RK, Huston JP (1996) The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 50(2–3):275–331CrossRefPubMedGoogle Scholar
  31. Schwarting RK, Huston JP (1997) Behavioral and neurochemical dynamics of neurotoxic mesostriatal dopamine lesions. Neurotoxicology 18(3):689–708PubMedGoogle Scholar
  32. Urbain N, Rentero N, Gervasoni D, Renaud B, Chouvet G (2002) The switch of subthalamic neurons from an irregular to a bursting pattern does not solely depend on their GABAergic inputs in the anesthetic-free rat. J Neurosci 22:8665–8675PubMedGoogle Scholar
  33. Urbain N, Creamer K, Debonnel G (2006) Electrophysiological diversity of the dorsal raphe cells across the sleep-wake cycle of the rat. J Physiol 573:679–695CrossRefPubMedCentralPubMedGoogle Scholar
  34. Vargo JM, Marshall JF (1996) Unilateral frontal cortex ablation producing neglect causes time-dependent changes in striatal glutamate receptors. Behav Brain Res 77(1–2):189–199CrossRefPubMedGoogle Scholar
  35. Wiley RG (1992) Neural lesioning with ribosome-inactivating proteins: suicide transport and immunolesioning. Trends Neurosci 15(8):285–290CrossRefPubMedGoogle Scholar
  36. Wiley RG (1997) Findings about the cholinergic basal forebrain using immunotoxin to the nerve growth factor receptor. Ann NY Acad Sci 835:20–29CrossRefPubMedGoogle Scholar
  37. Wiley RG (2001) Targeting toxins to neural antigens and receptors. Methods Mol Biol 166:267–276PubMedGoogle Scholar

Copyright information

© Springer-Verlag France 2014

Authors and Affiliations

  • Barbara Ferry
    • 1
  • Damien Gervasoni
    • 1
  • Catherine Vogt
    • 2
  1. 1.Lyon Neuroscience Research Centre CNRS UMR 5292–INSERM U 1028Université Claude Bernard Lyon 1LyonFrance
  2. 2.Université Claude Bernard Lyon 1LyonFrance

Personalised recommendations